Study discovers method to classify febrile illness with a single blood sample

FHS
August 28, 2023
10:33 am

Researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood.

Hims’ push into compounded GLP-1 drugs risks scrutiny from Novo Nordisk

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The digital health company Hims & Hers

May 22, 2024

NICER: A safer alternative to CRISPR/Cas9 for gene editing

The gene editing technique CRISPR/Cas9 has allowed researchers to make precise and impactful changes to an organism’s DNA to fix mutations that cause genetic disease.

September 15, 2023

New biomaterial could change the way human tissue can be grown in the lab

Scientists at UNSW Sydney have created a new material that could change the way human tissue can be grown in the lab and used in

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.